iodine-131

(redirected from I-131)
Also found in: Dictionary, Thesaurus, Medical.

iodine-131

[′ī·ə‚dīn ¦wən¦thərd·ē′wən]
(nuclear physics)
A radioactive, artificial isotope of iodine, mass number 131; its half-life is 8 days with beta and gamma radiation; used in medical and industrial radioactive tracer work; moderately radiotoxic.
References in periodicals archive ?
The peripheral blood samples of 20 patients who were diagnosed as having thyroid cancer, whose ages ranged between 18-72 years and who were decided to undergo I-131 ablation/treatment were used as study materials.
While the majority of patients received I-131 (91%), the applied activity and number of applications varied, reffecting tumor specific features that guided therapeutic approach.
(3-5) This study confirms that the incidence of second primary malignancies after treatment with I-131 for thyroid cancer increased significantly.
Kr-88, Xe-133, and Xe-135 are the nuclides with the three greatest activity concentrations, and I-131 has the lowest activity concentration.
He had levothyroxine withdrawal I-131 whole body scan (WBS) in 1984 and 2002 that showed no evidence of residual or metastatic disease.
The patient underwent surgical excision of the calcaneal tumor and bone grafting followed by I-131 therapy.
Cuando se confirma malignidad se discute interdisciplinarimente la posibilidad de terapia con I-131, la cual se administro a pesar de ser tardiamente, por la evidencia de incremento progresivo de la tiroglobulina obteniendo captacion positiva del mismo que, sin embargo, presento recaida posterior.
A parole application (Form I-131, Application for Travel Document) along with the required fee (or fee waiver request) for each relative to be considered for parole; and
[USPRwire, Mon Mar 21 2016] North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), by Application (Oncology, Cardiology) - Forecasts to 2020
Uso de yodo radiactivo I-131 y monitorizacion de radiactividad en pacientes con enfermedad renal cronica en hemodialisis.
The prognostic factors described in this system include incomplete tumor resection, aggressive histology subtypes, tumor invasion, cervical lymph node metastasis, distant metastasis and I-131 uptake outside the thyroid bed on whole-body scans (WBSs) undertaken after thyroid remnant ablation.